C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
暂无分享,去创建一个
G. Beck | A. Levey | T. Greene | J. Kusek | M. Sarnak | A. Collins | Xuelei Wang | S. Marcovina | V. Menon | Arema A. Pereira
[1] Natalia S. Rost,et al. Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.
[2] A. Hofman,et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[3] L. Lissner,et al. Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. , 1999, Obesity research.
[4] W. Owen,et al. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. , 1998, Kidney international.
[5] M. Raftery,et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] D. Levy,et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.
[7] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[8] D. Nicol,et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? , 2001, Journal of the American Society of Nephrology : JASN.
[9] A. Levey,et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.
[10] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.
[11] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[12] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[13] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[14] C. Pollock,et al. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] K. Iseki,et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] R. Kronmal,et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. , 2003, Journal of the American College of Cardiology.
[17] J. Manson,et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. , 2004, Journal of the American Society of Nephrology : JASN.
[18] Deeb N Salem,et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.
[19] G Block,et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] Deeb N Salem,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.
[21] L H Kuller,et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[22] C. Wanner,et al. Inflammation and cardiovascular risk in dialysis patients. , 2002, Kidney international. Supplement.
[23] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[24] R. Petersen,et al. Clinical Subtypes of Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.
[25] G. Kaysen,et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[27] David C. Murray,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.
[28] E. Ford. Body mass index, diabetes, and C-reactive protein among U.S. adults. , 1999, Diabetes care.
[29] R. Foley,et al. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. , 1996, Journal of the American Society of Nephrology : JASN.
[30] R. Foley,et al. Epidemiology of cardiovascular disease in chronic renal disease , 2000 .
[31] L. Lind. Circulating markers of inflammation and atherosclerosis. , 2003, Atherosclerosis.
[32] L. Snetselaar,et al. Baseline characteristics in the Modification of Diet in Renal Disease Study. , 1993, Journal of the American Society of Nephrology : JASN.
[33] G. Beck,et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] Seoung Woo Lee,et al. Serum C-Reactive Protein: A Predictor of Mortality in Continuous Ambulatory Peritoneal Dialysis Patients , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[35] P. Fein,et al. Markers for survival in dialysis: a seven-year prospective study. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] E G Lowrie,et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.
[37] P. Stenvinkel,et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.
[38] C. Wanner,et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.
[39] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[40] J. Walls,et al. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? , 2001, Kidney international.
[41] T. Drüeke. Aspects of Cardiovascular Burden in Pre-Dialysis Patients , 2000, Nephron.
[42] T. Strandberg,et al. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[43] K. Iseki,et al. Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.
[44] J. Pankow,et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. , 2001, The American journal of cardiology.